ICP
CNMD icon

Interchange Capital Partners’s CONMED CNMD Stock Holding History

Interchange Capital Partners’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-345
Closed -$38K – 394
2020
Q4 		$38K Buy
+345
New +$32.7K 0.02% 456

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Interchange Capital Partners's CNMD Position: Q1 2021 in Review

Interchange Capital Partners sold out of CONMED (CNMD) in Q1 2021, closing a stake of 345 shares — an estimated $38K sold.

Interchange Capital Partners first reported a position in CNMD in Q4 2020 and held it in 1 quarter. The position peaked at $38K in Q4 2020. 239 funds tracked by Wall St. Rank hold CNMD as of Q1 2021.

  • Interchange Capital Partners reported no remaining CONMED position as of Q1 2021 after selling out during the quarter.
  • Interchange Capital Partners sold 345 CONMED shares in Q1 2021, an estimated $38K.
  • Interchange Capital Partners first reported a position in CONMED in Q4 2020 and held it in 1 quarter.
  • Interchange Capital Partners's CONMED position peaked at $38K in Q4 2020.
  • 239 funds tracked by Wall St. Rank held CONMED as of Q1 2021.

Based on Interchange Capital Partners's 13F filing for Q1 2021, filed 5 May 2021.